Home | Welcome to Contract Pharma   
Last Updated Monday, January 26 2015

Print RSS Feed

Breaking News

May 2, 2013
To support diagnostic product development  Read More »
May 2, 2013
Earnings hit by lost generic Lipitor royalties  Read More »
May 2, 2013
Generic competition continues to hurt revenues  Read More »
May 2, 2013
Late-Stage Development revenues up 17%  Read More »
May 2, 2013
PCS sales up 6% in the quarter  Read More »
May 2, 2013
Revenues up 7% in the quarter  Read More »
May 1, 2013
Expands commercialization offering  Read More »
May 1, 2013
Evaluates relationships, effectiveness, and reputation  Read More »
May 1, 2013
Botox sales up 15% in the quarter  Read More »
May 1, 2013
Quality and product related charges contribute to losses  Read More »
May 1, 2013
Singulair expiry continues to impact results  Read More »
May 1, 2013
Revenues up 27% in the quarter  Read More »
April 30, 2013
Revenues disappoint, but new products rise  Read More »
April 30, 2013
Expands presence in oncology, inflammation and autoimmune diseases  Read More »
April 30, 2013
Aims to address logistical constraints of currently available vaccine  Read More »



Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On